Yildirim, H. Et Al. 2024. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma. ESMO OPEN , vol.9, no.9 , 9-10.

Yildirim, H., Bayram, E., Chalabiyev, E., Mecidova, N., Avci, T., Güzel, H., ... Kapar, C.(2024). Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma. ESMO OPEN , vol.9, no.9, 9-10.

Yildirim, H.C. Et Al. "Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma," ESMO OPEN , vol.9, no.9, 9-10, 2024

Yildirim, H.C. Et Al. "Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma." ESMO OPEN , vol.9, no.9, pp.9-10, 2024

Yildirim, H. Et Al. (2024) . "Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma." ESMO OPEN , vol.9, no.9, pp.9-10.

@article{article, author={H.C. Yildirim Et Al. }, title={Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma}, journal={ESMO OPEN}, year=2024, pages={9-10} }